Decheng Capital Management III as of June 30, 2023
Portfolio Holdings for Decheng Capital Management III
Decheng Capital Management III holds 25 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alabama Power Co. p | 21.6 | $69M | 6.7M | 10.28 | |
| Zentalis Pharmaceuticals (ZNTL) | 18.6 | $59M | 2.1M | 28.21 | |
| Acelyrin (SLRN) | 10.2 | $33M | 1.6M | 20.90 | |
| 10x Genomics Cl A Com (TXG) | 6.3 | $20M | 360k | 55.84 | |
| Pacific Biosciences of California (PACB) | 6.1 | $20M | 1.5M | 13.30 | |
| Arcus Biosciences Incorporated (RCUS) | 5.5 | $18M | 870k | 20.31 | |
| Illumina (ILMN) | 4.8 | $15M | 81k | 187.49 | |
| Roivant Sciences | 4.6 | $15M | 1.5M | 10.08 | |
| Phathom Pharmaceuticals (PHAT) | 3.8 | $12M | 850k | 14.32 | |
| Argenx SE SHS (ARGX) | 3.4 | $11M | 27k | 389.73 | |
| Horizon Therapeutics | 2.5 | $8.1M | 79k | 102.85 | |
| Terns Pharmaceuticals (TERN) | 2.0 | $6.2M | 714k | 8.75 | |
| BeyondSpring SHS | 1.8 | $5.9M | 5.0M | 1.18 | |
| Seattle Genetics | 1.4 | $4.4M | 23k | 192.46 | |
| Aura Biosciences (AURA) | 1.1 | $3.6M | 293k | 12.35 | |
| Aadi Bioscience (AADI) | 1.1 | $3.6M | 526k | 6.84 | |
| Equillium (EQ) | 1.0 | $3.3M | 4.4M | 0.75 | |
| Cue Health (HLTHQ) | 1.0 | $3.3M | 9.0M | 0.37 | |
| Mersana Therapeutics (MRSN) | 0.9 | $3.0M | 904k | 3.29 | |
| AtriCure | 0.7 | $2.3M | 46k | 49.36 | |
| Scynexis Com New (SCYX) | 0.5 | $1.6M | 556k | 2.95 | |
| Adicet Bio (ACET) | 0.4 | $1.2M | 506k | 2.43 | |
| Apexigen | 0.3 | $814k | 1.9M | 0.43 | |
| GeneDx Holdings Corp. Com Cl A | 0.2 | $618k | 104k | 5.96 | |
| Neubase Therapeutics Ord | 0.0 | $93k | 50k | 1.85 |
